Pacira Biosciences Inc (PCRX)

SG&A Expense Growth

-2.27%

Quarterly · Period ending:

PCRX logo

PCRX SG&A Expense Growth

Latest reported-2.27%
PCRX Quarterly SG&A Growth (QoQ) (0.00% → -2.27%)
High-resolution chart · PNG

PCRX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-2.2726%
-7.5427%
10.6877%
3.6341%
2.0766%
8.9959%
7.1045%
9.1111%
-5.4147%
9.4603%
-3.1583%
4.7756%
-8.4596%
10.7441%
4.3846%
-5.7228%
1.1562%
25.5005%
6.9939%
-5.8194%
4.7216%
-8.1597%
0.5175%
21.2704%
-3.2113%
-17.4151%
8.1691%
2.0397%
1.2531%
8.6702%
1.0593%
-0.1582%
0.1312%
12.7954%
-3.6069%
2.7609%
-6.0969%
21.4778%
-4.5189%
-16.8426%
15.0486%
1.0758%
6.3523%
1.6057%
10.5766%
1.3185%
9.9302%
13.6087%
9.9517%
11.982%
31.671%
8.8068%
8.8435%
-3.1954%
17.4459%
9.2673%
-6.6266%
66.597%
34.2021%
6.7866%
22.7595%
82.1446%
23.3176%
36.8336%
22.453%
-8.0909%
-30.8611%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.